Denmark Polymerase Chain Reaction Market Size & Outlook
Denmark polymerase chain reaction market, 2018-2030 (US$M)
Related Markets
Denmark polymerase chain reaction market highlights
- The Denmark polymerase chain reaction market generated a revenue of USD 356.0 million in 2023 and is expected to reach USD 113.6 million by 2030.
- The Denmark market is expected to grow at a CAGR of -15.1% from 2024 to 2030.
- In terms of segment, conventional pcr was the largest revenue generating type in 2023.
- Conventional PCR is the most lucrative type segment registering the fastest growth during the forecast period.
Polymerase chain reaction market data book summary
| Market revenue in 2023 | USD 356.0 million |
| Market revenue in 2030 | USD 113.6 million |
| Growth rate | -15.1% (CAGR from 2023 to 2030) |
| Largest segment | Conventional pcr |
| Fastest growing segment | Conventional PCR |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Conventional PCR |
| Key market players worldwide | Thermo Fisher Scientific Inc, Danaher Corp, Abbott Laboratories, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Qiagen NV, Roche Holding AG ADR, Standard BioTools Inc, Stilla, Microsynth |
Other key industry trends
- In terms of revenue, Denmark accounted for 1.1% of the global polymerase chain reaction market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany polymerase chain reaction market is projected to lead the regional market in terms of revenue in 2030.
- Norway is the fastest growing regional market in Europe and is projected to reach USD 58.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Polymerase Chain Reaction Market Scope
Polymerase Chain Reaction Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Denmark polymerase chain reaction market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to polymerase chain reaction market will help companies and investors design strategic landscapes.
Conventional pcr was the largest segment with a revenue share of 1.43% in 2023. Horizon Databook has segmented the Denmark polymerase chain reaction market based on conventional pcr covering the revenue growth of each sub-segment from 2018 to 2030.
6 million people. More than 45,000 incident instances of cancer were diagnosed in only 2019 alone. In Denmark, breast cancer affects more women than any other type of cancer, with 4,800 new cases diagnosed every year. The age range of the majority of breast cancer patients is between 50 and 70 years old.
A study conducted in partnership with researchers from the Steno Diabetes Center Copenhagen, Rigshospitalet, and the Department of Nutrition, Exercise, and Sports at the University of Copenhagen found that diabetes risk was enhanced after a cancer diagnosis.
However, cancer survival in Denmark has significantly increased. But for many survivors, complications and persistent effects decrease their quality of life. Several clinical trials are happening in the country. For instance, in May 2022, an article published in Focused Ultrasound Foundation stated that skin cancer clinical trial has begun in Denmark.
Reasons to subscribe to Denmark polymerase chain reaction market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Denmark polymerase chain reaction market databook
-
Our clientele includes a mix of polymerase chain reaction market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Denmark polymerase chain reaction market , including forecasts for subscribers. This country databook contains high-level insights into Denmark polymerase chain reaction market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Denmark polymerase chain reaction market size, by type, 2018-2030 (US$M)
Denmark Polymerase Chain Reaction Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
